You are here

China

Sanofi gets serious in China with plans to hire 300 for $76M R&D site in Chengdu

Endpoints

Mon, 07/2/18 - 10:38 pm

clinical trials

Big Pharma executives jump to China startups for higher pay and more say: report

Fierce Pharma

Wed, 06/20/18 - 09:49 am

With an AstraZeneca cancer drug in one hand, $37M in the other, Shanghai’s Alpha Bio zooms into a PhII study

Endpoints

Wed, 06/20/18 - 09:47 am

Bristol-Myers wins the frenzied race to a first approval for a PD-1/L1 checkpoint in China as regulators hustle up a quick OK

Endpoints

Fri, 06/15/18 - 09:37 am

Bristol-Myers Squibb

Sound familiar? China/US biotech hybrid lands rights to cancer drugs, cash and a team of development vets to launch Oncologie

Endpoints

Fri, 06/8/18 - 11:34 pm

Roche scrambles to boost Herceptin supply in China after insurance OK triggers shortage

Fierce Pharma

Wed, 06/6/18 - 09:33 am

Prepping a drug launch, Zai Lab poaches AstraZeneca’s top cancer drug sales exec in China

Endpoints

Tue, 06/5/18 - 12:06 pm

Trump tariffs leave medical device companies in the dark

Medical Design and Outsourcing

Thu, 05/31/18 - 10:55 am

China Focused Brii Biosciences Launches With $260 Million and Team of Industry Veterans

CP Wire

Thu, 05/24/18 - 09:56 am

Brii Biosciences

BeiGene Initiates Phase 3 Trial of Pamiparib as Maintenance Therapy in Patients with Ovarian Cancer

CP Wire

Thu, 05/17/18 - 12:03 pm

clinical trials

China's global investment push opens doors for domestic biotechs

Biopharma Dive

Wed, 05/9/18 - 09:41 pm

Belt and Road Initiative

Luye Pharma Buys Rights to Seroquel in China and Other Territories for $538 Million

CP Wire

Mon, 05/7/18 - 05:26 pm

Luye Pharma Group

Zoetis doubles down on animal vaccines

Biopharma Dive

Mon, 04/30/18 - 09:33 am

CANbridge Receives China FDA Approval for Oral Mucositis Therapy

CP Wire

Thu, 04/26/18 - 10:59 am

Trump tariffs threaten to cost medical device industry billions

Fierce Biotech

Tue, 04/10/18 - 11:50 am

Novartis, still embroiled in Greek probe, faces kickback allegation in China—again

Fierce Pharma

Fri, 04/6/18 - 11:24 am

Trump Tariffs Target Key Ingredients for Dozens of Drugs

Bloomberg

Wed, 04/4/18 - 09:56 pm

After a makeover and hiring spree, China’s drug agency is romping and stomping on new reviews and approvals

Endpoints

Thu, 03/29/18 - 09:55 am

Inovio Closes License and Collaboration Agreement with ApolloBio To Develop and Commercialize DNA Immunotherapy product (VGX-3100) in Greater China

CP Wire

Tue, 03/20/18 - 03:34 pm

DNAi-based therapeutics

China's Aim to Remove Cancer Drug Taxes May Boost Pfizer, Glaxo

Bloomberg

Tue, 03/20/18 - 09:59 am

Pages